Abucayon Erwin G, Rao Mangala, Matyas Gary R, Alving Carl R
U.S. Military HIV Research Program, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD 20910, USA.
Henry M. Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Drive, Bethesda, MD 20817, USA.
Pharmaceutics. 2023 Aug 26;15(9):2212. doi: 10.3390/pharmaceutics15092212.
Army Liposome Formulation with QS21 (ALFQ), a vaccine adjuvant preparation, comprises liposomes containing saturated phospholipids, with 55 mol% cholesterol relative to the phospholipids, and two adjuvants, monophosphoryl lipid A (MPLA) and QS21 saponin. A unique feature of ALFQ is the formation of giant unilamellar vesicles (GUVs) having diameters >1.0 µm, due to a remarkable fusion event initiated during the addition of QS21 to nanoliposomes containing MPLA and 55 mol% cholesterol relative to the total phospholipids. This results in a polydisperse size distribution of ALFQ particles, with diameters ranging from 50 nm to ~30,000 nm. The purpose of this work was to gain insights into the unique fusion reaction of nanovesicles leading to GUVs induced by QS21. This fusion reaction was probed by comparing the lipid compositions and structures of vesicles purified from ALFQ, which were >1 µm (i.e., GUVs) and the smaller vesicles with diameter <1 µm. Here, we demonstrate that after differential centrifugation, cholesterol, MPLA, and QS21 in the liposomal phospholipid bilayers were present mainly in GUVs (in the pellet). Presumably, this occurred by rapid lateral diffusion during the transition from nanosize to microsize particles. While liposomal phospholipid recoveries by weight in the pellet and supernatant were 44% and 36%, respectively, higher percentages by weight of the cholesterol (88%), MPLA (94%), and QS21 (96%) were recovered in the pellet containing GUVs, and ≤10% of these individual liposomal constituents were recovered in the supernatant. Despite the polydispersity of ALFQ, most of the cholesterol, and almost all of the adjuvant molecules, were present in the GUVs. We hypothesize that the binding of QS21 to cholesterol caused new structural nanodomains, and subsequent interleaflet coupling in the lipid bilayer might have initiated the fusion process, leading to creation of GUVs. However, the polar regions of MPLA and QS21 together have a "sugar lawn" of ten sugars, the hydrophilicity of which might have provided a driving force for rapid lateral diffusion and concentration of the MPLA and QS21 in the GUVs.
含QS21的军队脂质体制剂(ALFQ)是一种疫苗佐剂制剂,由含有饱和磷脂的脂质体组成,胆固醇与磷脂的摩尔比为55%,还含有两种佐剂,单磷酰脂质A(MPLA)和QS21皂苷。ALFQ的一个独特特征是形成直径大于1.0 µm的巨型单层囊泡(GUV),这是由于在将QS21添加到含有MPLA和相对于总磷脂55 mol%胆固醇的纳米脂质体过程中引发了显著的融合事件。这导致ALFQ颗粒的粒径多分散分布,直径范围从约50 nm到约30,000 nm。这项工作的目的是深入了解纳米囊泡独特的融合反应,该反应由QS21诱导产生GUV。通过比较从ALFQ中纯化的大于1 µm(即GUV)的囊泡和直径小于1 µm的较小囊泡的脂质组成和结构,对这种融合反应进行了探究。在此,我们证明经过差速离心后,脂质体磷脂双层中的胆固醇、MPLA和QS21主要存在于GUV中(在沉淀中)。据推测,这是在从纳米尺寸颗粒向微米尺寸颗粒转变过程中通过快速横向扩散发生的。虽然沉淀和上清液中脂质体磷脂的重量回收率分别为44%和36%,但在含有GUV的沉淀中,胆固醇(约88%)、MPLA(94%)和QS21(96%)的重量回收率更高,而这些脂质体成分在上清液中的回收率≤10%。尽管ALFQ具有多分散性,但大部分胆固醇以及几乎所有佐剂分子都存在于GUV中。我们假设QS21与胆固醇的结合导致了新的结构纳米域,随后脂质双层中的叶间偶联可能启动了融合过程,从而导致GUV的形成。然而,MPLA和QS21的极性区域共有十个糖组成的“糖草坪”,其亲水性可能为MPLA和QS21在GUV中的快速横向扩散和浓缩提供了驱动力。